Fixed drug eruption: topical provocation and subsequent phenomena.

J Coll Physicians Surg Pak

Department of Dermatology, Shaikh Zayed FPGMI, Lahore.

Published: December 2006

AI Article Synopsis

  • The study aimed to evaluate the effectiveness of topical provocation testing for identifying drugs responsible for fixed drug eruptions (FDE).
  • Over a three-year period, 305 patients underwent tests where different concentrations of drug ointments were applied to normal skin and observed for reactions.
  • Results indicated a significant correlation between the strength of drug preparations and positive responses, with sulphamethoxazole identified as the most common drug causing FDE.

Article Abstract

Objective: To determine the usefulness of topical provocation in detecting the incriminated drug causing fixed eruption.

Design: Quasi-experimental study.

Place And Duration Of Study: Department of Dermatology, Shaikh Zayed FPGMI, Lahore, from November 2002 to December 2005.

Patients And Methods: Three hundred and five, clinically diagnosed cases of Fixed Drug Eruption (FDE) of either gender and of any age were subjected to topical provocation with different drugs by using concentration of 1% (n=203), 2% (n=210) and 5% (n=235) in white soft paraffin. Drug ointment of one strength was applied one at a time on normal skin of flexor surface of right or left forearm. The effects of tests on involved and uninvolved skin were observed for 48 hours. The changes in lesions like erythema, hyperpigmentation, itching, burning or appearance of new lesion were considered a positive response. In case of no change, the patients (n=5) were subjected to oral provocation test, by giving half to full therapeutic dose of the suspected drug depending upon the severity of the initial attack. A patient who exhibited see-sawing phenomenon with 5% metamizole TPT was given oral challenge with same drug. Control topical tests were repeated in equal number of normal persons with various drug ointments and in patients of FDE with white soft paraffin on normal and affected skin.

Results: One hundred and thirty-seven patients were males and one hundred and sixty-eight patients were females. Maximum number of patients belonged to third decade. With 1% drug preparations 12 out of 316, with 2% drug preparations 28 out of 422 and with 5% drug preparations, 312 out of 523 TPTs were positive. The comparison revealed a highly significant association (Chi-square 448.1 and p < 0.000) among various strengths of preparations and positive response. Sulphamethoxazole was found to be the most commonly incriminated cause of FDE applied in 5% concentration yielded sensitivity rate of 91% compared to 4% with lower concentrations. Positive patch test was also observed with oxytetracycline. Five patients who were given oral provocation with different drugs were found to be positive to tinidazole, dapsone, propylphenazone, belladonna and phenobarbitone. Interesting phenomena like earlier reactivation of lesion situated distal to site of application of preparation, marching, see-sawing (with oral metamizole) and lightening observed, are not yet reported in literature.

Conclusion: Topical provocation test with 5% drug concentration applied on normal skin of patient with FDE is a possible first line investigation in finding the incriminated drug.

Download full-text PDF

Source

Publication Analysis

Top Keywords

topical provocation
16
drug preparations
12
drug
11
fixed drug
8
drug eruption
8
incriminated drug
8
provocation drugs
8
white soft
8
soft paraffin
8
normal skin
8

Similar Publications

Background: Abrocitinib, an oral small-molecule Janus kinase 1 (JAK1) inhibitor, has been widely accepted for the treatment of moderate-to-severe atopic dermatitis (AD). Currently there is a paucity of data on the adverse events (AEs) after abrocitinib treatment, especially on rare events such as exacerbation of facial dermatitis, and their causal relationship and subsequent management remains poorly elucidated.

Case Presentation: A 43-year-old female patient with moderate AD received dupilumab after failure of topical treatments.

View Article and Find Full Text PDF
Article Synopsis
  • Antihistamines are used to treat allergic reactions, but their effects can be slow, so combining them with fast-acting pain relievers might help alleviate discomfort from skin reactions.
  • The study aimed to assess the effectiveness and safety of a topical gel that combines diphenhydramine and lidocaine compared to a placebo in treating local skin inflammatory and allergic reactions.
  • Results showed that the combination gel significantly reduced itch intensity faster than the placebo, confirming its efficacy in alleviating discomfort from skin allergies.
View Article and Find Full Text PDF

[Basics in diagnostics and therapy of allergic diseases for ENT consultations].

Laryngorhinootologie

July 2024

Klinik für Hals-Nasen-Ohren-Heilkunde, Kopf- und Halschirurgie, Universitätsklinikum Mannheim, Mannheim, Germany.

Allergies play a pivotal role in the daily practice of ENT specialists. Allergic symptoms induced by inhalant allergens are widespread in the population and can manifest through a wide range of symptoms, including rhinorrhea, sneezing, conjunctival redness, cough and dyspnea. Inconsistent diagnosis and treatment of allergic conditions can lead to reduced quality of life, decreased work performance, and socioeconomically significant secondary diseases.

View Article and Find Full Text PDF

SIDeMaST (Società Italiana di Dermatologia Medica, Chirurgica, Estetica e delle Malattie Sessualmente Trasmesse) contributed to the development of the present guideline on the systemic treatment of chronic plaque psoriasis. With the permission of EuroGuiDerm, SIDeMaST adapted the guideline to the Italian healthcare context to supply a reliable and affordable tool to Italian physicians who take care of patients affected by atopic dermatitis. The evidence- and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual.

View Article and Find Full Text PDF

[Chronic rhinosinusitis with nasal polyposis : A retrospective analysis of therapeutic approaches in 463 patients].

HNO

July 2024

Klinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Halschirurgie, Universitätsklinik Ulm, Frauensteige 12, 89075, Ulm, Deutschland.

Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a multifactorial inflammatory disease, the treatment of which has undergone significant changes in recent years. In addition to surgical approaches, topical and systemic steroids, and adaptive acetylsalicylic acid (ASA) desensitization, three specific antibodies have complemented the therapeutic portfolio since 2019.

Methods: A retrospective evaluation of all patients who presented as outpatients for the first time due to CRSwNP in 2007 and 2008 (collective A) and 2017 and 2018 (collective B) was performed, up to and including June 2023.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!